Insulet PODD D&A
D&A at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Insulet's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Insulet's D&A?
- Insulet (PODD) reported D&A of $26.2M in Q1 2026.
- How has Insulet's D&A changed year-over-year?
- Insulet's D&A increased by 20.7% year-over-year, from $21.7M to $26.2M.
- What is the long-term trend for Insulet's D&A?
- Over 4 years (2021 to 2025), Insulet's D&A has grown at a 12.0% compound annual growth rate (CAGR), from $57.4M to $90.4M.
- What does D&A mean?
- The non-cash accounting expense for the wear and tear or expiration of assets.
- How do you interpret D&A?
- Higher values suggest a capital-intensive business model with significant investment in infrastructure or intellectual property.
- How does D&A compare across companies?
- Common in manufacturing and medical technology sectors where heavy investment in production equipment is required.